W hile systemic shortcomings in meeting the needs of individuals with progressive chronic illnesses at the end of life have been well-documented, there is growing interest in improving both care and quality of life for persons with advanced chronic obstructive pulmonary disease (COPD) (1) . In fact, the American Thoracic Society has issued an official statement on palliative care for patients with respiratory diseases (2) .
Individuals with advanced COPD experience poor quality of life and high levels of symptom burden typically including intractable dyspnea (3-7), fatigue (5, (8) (9) (10) (11) , significant disability (4) (5) (6) 9, 12, 13) , social isolation (9, 10, (12) (13) (14) , and high levels of anxiety and depression (4, 11, 15) . The caregiving burden for family members of people with advanced COPD is significant (13, (16) (17) (18) , particularly given the lack of resources available to support individuals with chronic illness in the community (5, 8, 10) .
In spite of the many unmet needs of patients with advanced COPD and their caregivers, disparities in access to specialized palliative care services at the end of life between patients with COPD and those with lung cancer have been widely reported (4, 19, 20) . Reasons for these disparities include 'prognostic paralysis', in which clinicians of patients with uncertain illness trajectories (such as COPD) procrastinate when considering the need for palliative care services; patient unwillingness to discuss endof-life care (21, 22) ; provider discomfort with initiating end-of-life dialogues (21) ; lack of financial resources (23); and lack of clinicians with expertise in the management of nonmalignant disease (23) . Finally, the relative lack of evidence regarding the impact of incorporating palliative approaches into the care of people with advanced COPD (20) suggests that significant gaps in our knowledge base and, hence, patient management, remain. Calls for a new model of care for people with advanced COPD, in which comprehensive palliative approaches are embedded within standard respiratory care, are becoming increasingly frequent (2, 24, 25) . The commitment to highquality care at the end of life is underpinned by a responsibility to evaluate and improve this care. Quality indicators (explicitly defined and measurable items referring to the structures, processes or outcomes of care [26] ) are one means by which to evaluate end-of-life care quality that have been previously used with cancer populations (27) (28) (29) . The primary focus at the Canadian consensus meeting was to discuss the applicability, development and monitoring of indicators measuring the quality of end-of-life care for individuals with advanced COPD.
The impetus for organizing this meeting was provided by the work two of the authors (DG, DM) had previously undertaken using administrative data to examine health care use of people with COPD who were in their last 12 months of life. 
MEEtinG OutCOMES
Based on the findings of a preliminary Delphi survey conducted by DG (methodology and findings to be reported elsewhere) and designed to develop a draft of end-of-life care quality indicators for persons with COPD, a set of eight statements formed the basis for the group's discussion. The initial statements were revised using consensus methods. Five statements (Table 1) emerged to reflect group opinion regarding critical process and outcome indicators of quality end-of-life care for individuals with advanced COPD (Table 2) .
FutuRE PlanS
Participants at the meeting agreed to move forward with an agenda to enhance end-of-life care for people with advanced The topic of end-of-life care planning should be first introduced by the health care provider most trusted by the patient, although physician involvement in the • decision-making process is crucial. Families and significant others play a pivotal role in planning for the end of life of people with advanced COPD. The involvement of and ongoing dialogue with family members and significant others in end-of-life care planning needs to be strongly encouraged by providers
Anticipating the need for end-of-life care
While accurate prediction of the trajectory of decline for a given individual with advanced COPD is challenging, the primary indicators that the patient is • approaching the end of life are: a) poor functional status (Medical Research Council dyspnea scale 4 to 5); b) severe acute exacerbation; c) FEV 1 less than 30% predicted; d) signs of respiratory failure or pulmonary hypertension; e) body mass index of less than 20 kg/m 2 ; or f) the patient is starting to wish for or talk about death. Deteriorating psychosocial/cognitive status and a pattern of increasing health care utilization are also useful indicators. Ongoing and focused monitoring (including the use of functional status scales such as the Palliative Performance Scale and the Bode Index) have prognostic value and should be used in both inpatient and home care settings
Advocating for patient and caregiver preferences as to the site of end-of-life care
The specific location of both care and death is less important for persons with advanced COPD than implementing end-of-life care in a setting of their choice that • accommodates both the patient's and caregiver's unique needs and preferences. The ability to access both inpatient and home support is a critical indicator of the quality of end-of-life care for people with advanced COPD. Alternative settings such as day hospices that may supplement care and relieve caregiver burden need to be explored
Optimizing interdisciplinary team care
End-of-life care is optimized through continuity of direct care providers and access to an interdisciplinary team. Knowledgeable family physicians, nurse • practitioners and case managers are the foundation of quality end-of-life care. Family physicians and home care teams should have access to the resources of both respiratory disease specialists and palliative care teams
Enhanced collaboration among respiratory care providers and palliative care services will optimize quality of care. While palliative care specialists have an • important role in consulting to provide symptom management, family physicians, respiratory specialists and home care providers must be trained to provide quality end-of-life care. Patients and families need clarification about the roles of each team member Specific initiatives designed to optimize end-of-life care for people with advanced COPD must be evaluated. These initiatives include 24 h emergency response • teams for community-based patients (including same-day in-home response), dedicated case managers, system navigator models, rapid access to respite and palliative care beds in nursing homes and hospitals, and access to outpatient symptom management clinics. A strong evidence base, generated by high-quality research for best practices in end-of-life care for this population, must be supported by appropriate and sustainable funding
Selecting interventions for patients with advanced COPD
Subjective symptom assessments (eg, Edmonton Symptom Assessment Scale) need to be routinely conducted in a consistent manner. Multidisciplinary • interventions must address the whole person and include psychosocial, spiritual and existential dimensions. Screening for depression, fatigue, anxiety and caregiver burden, as well as appropriate interventions to alleviate these concerns, are critical. The use of opioids to manage dyspnea at the end of life may be a beneficial intervention. Interventions designed to enhance exercise tolerance, nutritional status or treat infection must be considered • Symptom control is the most critical indicator of quality of end-of-life care. For this population, the symptoms of dyspnea, pain, depression, fatigue, anxiety and fear must be considered
• Both system and patient-centred measures provide additional information about how well we are caring for people dying from advanced chronic obstructive pulmonary disease. These include measures of:
• Continuity of care;
• Informal caregiver burden;
• Patient and family satisfaction with care;
• Quality of life during the months or years the person is living with advanced disease; and
• Timely, accurate communication between patients, caregivers and providers. Further investigation must occur to determine how to best measure each of these indicators and how to incorporate them into practice
